In a slightly different perspective, S1PR4 knockout in mice has been found to be beneficial in a cancer setting since it limited tumor progression through the accumulation of tumor-suppressive CD8+ T lymphocytes (Olesch et al., 2020). This evidence concerns the gene CD8A and neoplasm.